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Abstract 
L-Cysteine is an endogenous Sulphur containing amino acid with multiple and varied 
roles in the central nervous system, including neuroprotection and the maintenance of the 
redox balance. However, it was also suggested as an excitotoxic agent implicated in the 
pathogenesis of neurological disorders such as Parkinson´s and Alzheimer´s disease. L-
Cysteine can modulate the activity of ionic channels, including voltage-gated calcium 
channels and glutamatergic NMDA receptors, whereas its effects on GABAergic 
neurotransmission had not been studied before. In the present work, we analyzed the effects 
of L-Cysteine on responses mediated by homomeric GABAAρ1 receptors, which are known 
for mediating tonic GABA responses in retinal neurons. GABAAρ1 receptors were expressed 
in Xenopus laevis oocytes and GABA-evoked chloride currents recorded by two-electrode 
voltage-clamp in the presence or absence of L-Cysteine. L-Cysteine antagonized GABAAρ1 
receptor-mediated responses; inhibition was dose-dependent, reversible, voltage independent 
and susceptible to GABA concentration. Concentration-response curves for GABA were 
shifted to the right in the presence of L-Cysteine without a substantial change in the maximal 
response. L-Cysteine inhibition was insensitive to chemical protection of the sulfhydryl 
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groups of the ρ1 subunits by the irreversible alkylating agent N-ethyl maleimide. Our results 
suggest that redox modulation is not involved during L-Cysteine actions and that L-Cysteine 
might be acting as a competitive antagonist of the GABAAρ1 receptors. 
 
Introduction 
L-Cysteine (L-Cys) is an endogenous Sulphur containing amino acid that plays key 
roles in the central nervous system (CNS). Under physiological conditions, it is a rate-
limiting precursor for glutathione synthesis and takes part in the maintenance of the redox 
balance (Armstrong et al., 2004; Banerjee, 2012; Lu, 2013). 
 
L-Cys can exert contrasting effects on brain and retina, including neuroprotective and 
antioxidant activities (Miyamoto et al., 1989; de Melo Reis et al., 2007), as well as neurotoxic 
actions which were suggested to be involved in the pathogenesis of neurological disorders 
such as amyotrophic lateral sclerosis, Parkinson´s and Alzheimer´s disease, hypoxic/ischemic 
and hypoglycemic brain damage and retinal degeneration (Pedersen and Karlsen, 1980; 
Karlsen and Pedersen, 1982; Heafield et al., 1990; Slivka and Cohen, 1993; Janáky et al., 
2000; Gazit et al., 2004; Sawamoto et al., 2004). These and other evidence (Peana et al., 
2010; McBean et al., 2015), together with the fact that L-Cys is present in many dietary 
supplements (McPherson and Hardy, 2011), indicate that effects of L-Cys on 
neurotransmission might have clinical importance. 
 
L-Cys was also proposed as neuromodulator, based on studies showing that it is 
released on depolarization in a Ca
2+
-dependent manner from rat brain slices (Keller et al., 
1989) and produces synaptic actions, like inhibition of glutamate reuptake, activation of 
glutamate NMDA receptors or modulation of the activity of voltage-gated calcium channels 
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(Ferkany and Coyle, 1986; Pace et al., 1992; Nelson et al., 2005). However, the possible 
targets and action mechanisms of L-Cys throughout the CNS are not entirely understood and 
its actions on pre or post-synaptic elements of the GABAergic synapses had not been 
examined before. 
 
 GABAA receptors are GABA-gated pentameric chloride (Cl
-
) channels, members of 
the Cys-loop receptor superfamily, mediating most of the inhibitory neurotransmission in the 
CNS (Farrant and Nusser, 2005). Functionally distinct neuronal GABAA receptors arise from 
the combination of a variety of subunit subtypes (α1-6, β1-3, γ1-3, δ, ε, π, θ, ρ1-3). For 
example, heteromeric GABAAα1β2γ2 receptors are widely localized in brain and retina, 
where they mediate desensitizing ionic currents typically antagonized by bicuculline and 
modulated by benzodiazepines and barbiturates (Olsen and Sieghart, 2009). Meanwhile 
homomeric GABAAρ receptors, which are typically involved in several modes of inhibitory 
signaling in the retina (Matthews, 1994; Lukasiewicz et al., 2004; Jones and Palmer, 2009), 
display high affinity for GABA and mediate non-desensitizing responses which are highly 
resistant to bicuculline (Cutting et al., 1991; Polenzani et al., 1991; Naffa et al., 2017). 
GABAAρ receptors are highly expressed in retinal bipolar cells (Wässle et al., 1998; McCall 
et al., 2002). They play an important role in the control of axon terminal excitability 
mediating reciprocal synapses with amacrine cells (Dong and Werblin, 1998). They also 
mediate tonic inhibitory currents, which arise in response to ambient GABA locally 
controlled by GABA transporter 1 (GAT-1) transporters located on amacrine cells (Zhang 
and Slaughter, 1995; Lukasiewicz et al., 2004; Hull et al., 2006; Jones and Palmer, 2009). 
 
Based on the relevance of tonic GABAergic inhibition for retinal function we 
examined whether or not GABAAρ receptors can be target of L-Cys modulatory actions. In 
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the present work we analyzed the effects of L-Cys on responses mediated by human 
homomeric GABAAρ1 receptors in an in vitro cell model (Beltrán González et al., 2014). 
GABAAρ1 receptors were heterologously expressed in Xenopus laevis oocytes and GABA-
induced Cl
-
 currents electrophysiologically recorded. Our results showed that L-Cys inhibits 
the activity of GABAAρ1 receptors. Experiments involving the chemical modification of 
sulfhydryl groups suggest that redox mechanisms were not involved in L-Cys actions and that 
inhibitory actions are more likely explained by a competitive antagonism operating on the 
GABAAρ1 receptors. 
 
Materials and methods 
Experiments were carried out in accordance with the Guide for the Care and Use of 
Laboratory Animals as adopted and promulgated by the U.S. National Institutes of Health 
(https://grants.nih.gov/grants/olaw/Guide-for-the-Care-and-Use-of-Laboratory-Animals.pdf), 
and were approved by the Institution’s Animal Care and use Committee. 
 
RNA preparation, oocyte isolation and cell injection 
Human cDNA encoding the ρ1 GABAA receptor subunit, cloned in the in vitro 
transcription-suitable vector pGEM, was used as a template to synthesize cRNAs in vitro. 
cRNA solutions (0.3-1 ng/nl) were prepared in RNAse-free H2O and stored at –70ºC. 
Xenopus laevis (Nasco, Modesto, CA, USA) oocytes at stages V and VI were used for 
expression of exogenous cRNAs. Isolation and maintenance of cells were carried out as 
previously described (Goutman et al., 2005). Brieﬂy, frogs were anesthetized with 3-
aminobenzoic-acid ethylester (~1 mg/ml) and ovaries surgically removed. Ovaries were 
incubated with 400 U/ml collagenase for 4 h at 23–24ºC and isolated oocytes maintained in 
an incubator at 18ºC in Barth’s medium (in mM: 88 NaCl; 0.33 Ca(NO3)2; 0.41 CaCl2; 1 
KCl; 0.82 MgSO4; 2.4 NaHCO3; 10 HEPES , 0.05 mg/ml gentamicin and 0.05 mg/ml 
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tetracycline ; pH adjusted to 7.4 with NaOH). After 1 day, each oocyte was manually 
microinjected (microinjector Drummond Sci. Co., Broomall, PA, USA) with 50 nl of a 
solution containing 5–50 ng of cRNA. 
 
Electrophysiological recordings 
TEVC recordings were performed 3–7 days after oocyte injection, with an Axoclamp 
2B ampliﬁer (Axon Instruments, Union City, CA, USA). Standard glass recording electrodes 
were made in a Narishige PB-7 puller (Narishige Scientiﬁc Instrument Lab., Tokyo, Japan) 
and ﬁlled with 3 M KCl. Pipette resistance values were approximately 1 MΩ. The holding 
potential was set to -70 mV and current traces acquired by a PC through a Labmaster TL-1 
DMA interface (Scientiﬁc solutions Inc., Solon, OH, USA) using AXOTAPE software (Axon 
Instruments). I-V curves consisted of voltage stepped ramps from -120 to +40 mV, in 2 sec 
steps, starting from a holding potential of -70 mV. Ramps were delivered at the plateau of the 
GABA responses, in the presence or absence of L-Cys. Leak currents were estimated through 
voltage ramps performed on the baseline (before and after GABA application) and then were 
digitally subtracted. Cells were placed in a chamber (volume 100 µl) continuously super-
fused (12 ml/min) with frog Ringer’s solution (in mM: 115 NaCl; 2 KCl; 1.8 CaCl2; 5 
HEPES; pH 7.0). GABA and other drugs were applied through the perfusion system. Drugs 
were freshly prepared each day as concentrated stocks and dissolved in frog Ringer´s 
solution. The pH of each test solution was always checked and adjusted if necessary to 
pH=7.0. All the experiments were carried out at room temperature (23–24ºC) and were 
replicated in at least 5 different oocytes isolated from at least two different frogs.  
Materials 
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The transcription kit mMessage mMachine was purchased from Ambion (Austin, TX, 
USA) and type II collagenase from Worthington (Freehold, NJ, USA). All chemicals and 
salts were purchased from Sigma-Aldrich (St Louis, MO, USA).  
 
Data analysis  
Data were analyzed with Prism v. 6.0 (Graphpad Software, Inc. San Diego, CA, 
USA). Concentration–response curves for GABA were ﬁt with a logistic equation of the 
following form: IGABA/B = [A
n
/(A
n
+EC50
n
)] x 100 where A is the agonist concentration, B the 
maximal response, EC50 the concentration of agonist that elicits half-maximal responses and 
n the Hill coefﬁcient. Percentage of control response was calculated as [(IGABAρ1L-Cys x 100 / 
IGABAρ1control)], where IGABAρ1L-Cys indicates the current amplitude evoked at each particular 
GABA concentration in the presence of L-Cys and IGABAρ1control the corresponding responses 
in the absence of modulator. Percentage of inhibition was calculated as [100 - (IGABAAρ1L-Cys x 
100 / IGABAAρ1control)]. Student´s t-tests (two tailed) were employed to evaluate signiﬁcant 
differences between parameters. In all cases errors were expressed as SEM. 
 
Results 
Inhibition of GABA-mediated currents by L-Cysteine  
GABA applications to oocytes expressing homomeric GABAAρ1 receptors induced 
non-desensitizing inward Cl- currents displaying all features of the bicuculline resistant 
GABA receptor mediated responses typically found in the retina (Polenzani et al., 1991; 
Zhang et al., 2001; Hull et al., 2006). They were antagonized by TPMPA and picrotoxin and 
displayed the characteristic pharmacological profile for agonists (data not shown) (Kusama et 
al., 1993; Woodward et al., 1993; Ragozzino et al., 1996; Naffa et al., 2017).  Fig. 1 
illustrates the effects of L-Cys on GABAAρ1 receptor-mediated responses evoked by 1 μM 
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GABA, a concentration close to the EC50 of GABA for these receptors, at -70 mV. Short bath 
applications of L-Cys significantly inhibited GABA responses (Fig. 1A and 1B). 
Antagonistic actions were dose-dependent, showed fast onset and completely reversed after 
washout. In the absence of GABA, L-Cys applications (200 μM) performed on either mRNA-
injected or sham oocytes did not produce noticeable effects on oocyte properties such as 
membrane potential, membrane resistance or current baseline under voltage-clamp (n=7; data 
not shown). No changes in the degree of inhibition were observed when consecutive GABA-
evoked responses (1 μM GABA) were recorded in the continued presence of a single 
concentration of L-Cys (200 μM) (Fig. 1C), indicating that L-Cys effects on GABAAρ1 
receptors are not use-dependent (Goutman and Calvo, 2004). 
Concentration-response (C-R) curves for GABA were performed either in the absence 
or presence of L-Cys (Fig. 2A; parameters detailed in Table 1). L-Cys shifted the C-R curve 
for GABA to the right, that is increased the EC50 without a substantial change in the 
maximal response. These results indicated that in the presence of L-Cys the apparent affinity 
of GABAAρ1 receptors decreased. L-Cys inhibition strongly depended on GABA 
concentration (Fig. 2B), with the degree of antagonism declining as GABA concentration 
increased. Currents evoked by 0.3 μM GABA were inhibited in a 76.8 ± 4.4 % (n = 8, p < 
0.0001), whereas currents evoked by 10 μM GABA were inhibited in a 2.6 ± 0.9 % (n = 13, 
ns). For GABA concentrations lower than 3 μM, inhibition induced by 200 μM L-Cys was 
always significant (p < 0.001). The effects of increasing doses of L-Cys were tested on 
responses evoked by different GABA concentrations: 0.3 μM (A), 1μM (B) and 10 μM (C) 
(n = 5-10) (Fig. 2C). The effects of L-Cys on GABAAρ1 receptor- mediated responses were 
particularly pronounced at GABA concentrations within the dynamic range of activation, but 
almost negligible at saturating values of GABA. At 0.3 μM GABA, inhibition was 
significant for all L-Cys concentrations tested (10 μM to 3 mM) and at 1 μM GABA, effects 
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were significant for concentrations above 20 μM (n = 6, p < 0.02). Meanwhile, at 10 μM 
GABA, inhibition was only significant for levels of L-Cys above 500 µM (n = 10, p < 0.02). 
Current-voltage relationships (I-V curves), performed in the presence or absence of 
200 μM L-Cys, showed a change in the slope without alterations in the linearity of the I–V 
relationship or the reversal potential (between -120 and 40 mV for 1 µM GABA-elicited 
responses), demonstrating that effects on GABAAρ1 receptors did not depend on the 
membrane potential and neither were due to variations in intracellular Cl
-
 levels (Fig. 2D).  
 
Modulation of GABAAρ1 receptors by L-Cysteine is not affected by N-ethyl-maleimide 
treatment  
L-Cys had been previously shown to be a redox modulator of T-type calcium channels 
in rat peripheral nociceptors (Todorovic et al., 2001; Nelson et al., 2005). In addition, we had 
also observed that reducing and oxidizing thiol agents are effective modulators of the 
GABAAρ1 receptor function (Calero and Calvo, 2008; Gasulla et al. 2012; Beltrán González 
et al., 2014). In fact, many different ionic channels sensitive to redox modulation usually are 
chemically modified through oxidation of cysteine residues. Based on all these data, we 
decided to test if redox modulation of cysteine residues might also be involved in the actions 
of L-Cys on GABAAρ1 receptors. 
 
  At first view, the rapid onset and reversible effect of L-Cys on the GABAAρ1 
receptor mediated responses would be consistent with a direct redox modulatory action and 
thiol groups located at the ρ1 subunits would be the most reactive redox candidates. Each ρ1 
subunit contains only two molecular sites contributing potential reactive cysteines, namely 
the extracellular Cys-loop and the single intracellular (C364) (Sedelnikova et al., 2005; Lo et 
al., 2008). However, it is important to state that redox modulation of the GABAAρ1 receptors 
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mediated by these cysteine residues was sensitive to N-ethyl-maleimide (NEM) treatment in 
all cases examined before (Calero et al., 2011; Gasulla et al., 2012; Beltrán González et al., 
2014). NEM is a membrane permeable irreversible alkylating reagent which selectively forms 
covalent bonds with free sulfhydryl groups, preventing any further chemical reaction at these 
sites (at pH = 7.0) (Means and Feeney, 1971). During the present experiments NEM 
concentration was kept as low as possible and incubation periods maintained very short in 
order to avoid non-specific effects (Calero et al., 2011). Pre-incubation for 2 min with 30 μM 
and 300 μM NEM failed to prevent L-Cys induced inhibition (% Control Response L-Cys = 
32.7 ± 4.7 % (n = 5), + NEM 30μM = 40.1 ± 6.8 % (n = 6), + NEM 300μM = 40.8.1 ± 6.4 % (n = 
6), ns) (Fig. 3). Taken together, these results suggest that redox modulation is not involved 
during GABAAρ1 responses inhibition by L-Cys.  
 
GABAAρ1 receptors function is insensitive to L-Cystine and L-Homocysteine 
The specificity of L-Cys actions on GABAAρ1 responses was analyzed by testing the 
closely related compounds L-Cystine and L-Homocysteine, which also have physio-
pathological relevance (Cherqui et al., 2002; Mattson and Shea, 2003; Isobe et al., 2005; 
Ajith and Ranimenon, 2015) and whose actions on GABAAρ1 receptor mediated responses 
had not been previously examined. Application of L-Cystine (200 μM) did not produce 
significant effects on responses elicited by 0.3 μM (103.8 ± 5.3 % (n = 8) ns) or 1 μM GABA 
(101.7 ± 1.2 % (n = 5) ns). L-Homocysteine (200 μM) showed no significant effect either on 
responses elicited by 0.3 μM (107.7 ± 6.3 % (n = 5) ns) or 1 μM GABA (99.3 ± 0.8 % (n = 6) 
ns). Representative experiments are illustrated in Fig 4. 
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Discussion 
The present findings are the first to demonstrate that the ubiquitous and endogenous 
amino acid L-Cys can modulate the function of GABAA receptors. Our results show that L-
Cys is capable to induce functional changes on homomeric GABAAρ1 receptors, a GABAA 
receptor subtype highly expressed in the retina that mediates tonic GABA responses in 
bipolar cells. 
 
Mechanisms underlying the inhibition of GABAAρ1 receptors by L-Cysteine  
Inhibition of GABAAρ1 receptors by L-Cys was reversible, dose-dependent, voltage-
independent and strongly susceptible to GABA concentration. The rapid onset of inhibition 
was consistent with an extracellular mechanism of action taking place. Experiments with 
NEM suggested that antagonistic actions of L-Cys are not due to redox modulation of 
cysteine residues at the GABAAρ1 receptors. Interactions of thiol compounds, like L-Cys, 
with traces of transition metal ions can potentially generate oxygen free-radical species by 
Haber-Weiss type reactions (Janáky et al., 2000). However, an indirect action of L-Cys on 
GABAAρ1 receptors through this mechanism seems not to be the case, because previous 
studies in our laboratory showed that oxygen free radicals potentiated GABAAρ1 responses 
with a slow onset through an interaction with the intracellular cysteine residues of the ρ1 
subunits (Beltrán González et al., 2014), in sharp contrast to the fast inhibition observed here 
following L-Cys applications. 
 
L-Cys induced a rightward parallel shift in the C-R curve for GABA without changing 
the maximum response and the Hill coefficient. In addition, GABAAρ1 receptor antagonism 
by L-Cys was surmounted by increasing the GABA concentration and did not involve use-
dependent processes. Taken together, these results suggest that L-Cys shares the 
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characteristics of other competitive antagonists acting at on the GABAAρ1 receptors 
(Woodward et al., 1993). However, binding studies will be necessary to confirm this 
assumption. Finally, neither L-Cystine nor L-Homocysteine, structural analogs of L-Cys, had 
effect on GABAAρ1 responses evoked at concentrations in which L-Cys exhibited significant 
effects. Thus, structural determinants are essential for L-Cys modulation. 
 
Possible physiological relevance of the modulation of ionotropic GABAAρ1 receptors by L-
Cysteine. 
GABAAρ1 receptors provide significant inhibitory drive to the synaptic terminals of 
retinal bipolar cells, including tonic, reciprocal and lateral inhibition (Zhang and Slaughter, 
1995; Lukasiewicz et al., 2004; Hull et al., 2006; Chávez et al., 2010). In this context, the 
inhibition of GABAAρ1 receptors responses by L-Cys could eventually increase the 
excitability of the bipolar cells, shaping ganglion cell responses and raising the excitability of 
the visual pathway. However, whether or not L-Cys modulation represents a relevant 
mechanism for controlling the activity of these and other ionotropic GABA receptors in 
retinal neuronal circuits, under physiological or pathological conditions, will need to be 
assessed by using both retinal slices and in vivo models.  
 
The study of endogenous agents, such as L-Cys, as modulators of ionotropic GABA 
receptors broadens the understanding of the control of the phasic and tonic GABAergic 
neurotransmission and could eventually shed light on the etiology of several neurological 
disorders and the development of therapeutic applications. The extracellular concentrations of 
L-Cys used here were far below the range of those commonly used in previous work (Pace et 
al., 1992; Todorovic et al., 2001; Nelson et al., 2005). Even though effects on GABAAp1 
receptors were significant L-Cys is normally found in relatively low levels in brain (ca. 0.05 
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μmol/g), compared for example to the cysteine-containing tripeptide, glutathione (GSH, ca. 
1.5 μmol/g). However, L-Cys was estimated to reach up to a level equivalent to a 
concentration of 700 µM in the course of ischemic brain damage (Slivka and Cohen, 1993). 
In our study, antagonistic actions of L-Cys on GABAAρ1 receptors were detected even at 35-
fold lower concentration than that. Given the potential clinical relevance of L-Cys effects on 
GABA neurotransmission, the extensive use of L-Cys as food additive or nutraceutical 
(McPherson and Hardy, 2012), together with the fact that ionotropic GABA receptors are the 
most important inhibitory receptors in the brain, it will be important in future studies to 
establish if L-Cys can serve as signaling mediator regulating the activity of different GABAA 
receptors subtypes in the CNS. 
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Table 1 
 EC50 (µM) nH Max Response (%) n 
Control 0.92 ± 0.07 2.26 ± 0.05 99.34 ± 0.28 11 
+ 50 µM L-Cys 1.21 ± 0.14 2.06 ± 0.09 100.60 ± 0.83 6 
+ 200 µM L-Cys 2.24 ± 0.12 2.09 ± 0.09 102.30 ± 0.97 5 
+ 1 mM L-Cys 3.95 ± 0.17 2.62 ± 0.12 102.20 ± 0.82 5 
+ 2 mM L-Cys 6.71 ± 0.14 3.13 ± 0.09 101.00 ± 0.45 6 
 
Legends 
Fig 1 
Antagonistic effects of L-Cys on responses mediated by GABAAρ1 receptors expressed in 
Xenopus laevis oocytes. Representative traces of GABAAρ1 receptor-mediated Cl
-
 currents 
elicited by 1 μM GABA. Applications of 20 μM (A) and 200 μM (B) L-Cys, indicated as 
bars, were performed at the plateau of the GABA-evoked responses. (C) Representative 
traces of currents recorded during repeated co-applications of 1 μM GABA and 200 μM L-
Cys. L-Cys was applied 1 min before the first co-application with GABA and kept 
continuously present until the end of the third GABA application. Recording of the GABA 
responses were separated by 2 min interval. In this and the following figures oocytes were 
voltage-clamped at −70 mV. Scale bars indicate current amplitude (y-axis) and time (x-axis). 
 
Fig 2 
Analysis of L-Cys effects on GABAAρ1 receptors. (A) C-R curves for GABA, in the 
presence and absence (●) of 50 μM (□), 200 μM (▲), 1 mM (▽) and 2 mM (■) L-Cys. 
Response amplitudes were expressed as a fraction of maximal current values, evoked at 100 
μM GABA (n = 5-11). (B) Inhibition produced by 200 μM L-Cys on GABAAρ1 receptor 
currents induced by increasing concentrations of GABA. Data were expressed as percentage 
of inhibition (n = 5-13). (C) Inhibition curves performed for GABAAρ1 receptor currents 
elicited by 0.3 μM (▲), 1 μM (■) and 10 μM (●) GABA in the presence of increasing 
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concentrations of L-Cys. Data were expressed as percentage of change relative to control 
values (n = 5-10). (D) Representative trace of an I-V relationship for GABAAρ1 receptor 
responses evoked by 1 μM GABA in the presence (▲) or absence (●) of 200 μM L-Cys. The 
reversal potential of GABA currents was not modified.  
 
Fig 3 
Cysteine thiols are not involved in L-Cys inhibition of GABAAρ1 receptor-mediated 
responses. (A) Representative trace of two successive GABAAρ1 responses elicited by 1 μM 
GABA. The control response was followed by a pre-treatment of the oocyte with 30 μM 
NEM (for 150 sec). Irreversible cysteine blockade by NEM did not prevent the inhibition 
induced on GABA responses by applications of 200 μM L-Cys. (B) Data expressed as 
percentage of change relative to control values. Equivalent results were obtained using 30 μM 
or 300 μM NEM (n = 5-6). 
 
Fig 4 
L-Cystine and L-Homocysteine did not produce effects on GABAAρ1 receptor-mediated 
responses. Representative traces of GABAAρ1 responses elicited by 0.3 μM GABA during 
application of 200 μM L-Cystine (A) and 200 μM L-Homocystine (B). 
 
Table I 
Parameters estimated from the fit of C-R curves for GABA, performed in the absence or 
presence of L-Cys. EC50 is the concentration that evokes a half maximal response, nH the 
Hill coefficient and n the number of data sets. Data are the mean ± S.E.M.  
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